Genus plc

British biotechnology company

London SE ISIN GB0002074580 LEI 54930022EOITNKSIGH56
Follow Genus Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2026 GBP · IFRS
Revenue, last year £658.1M −2.2% vs prior year
Net income £285.3M +1378.2% vs prior year
EPS, diluted £4.25 +1370.9% vs prior year
Operating cash flow £74.4M +10.7% vs prior year
Revenue by fiscal year
£593.4M
£689.7M
£668.8M
£672.8M
£658.1M
FY22 FY23 FY24 FY25 FY26

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income5 fiscal years
  • Revenue
  • Net income
£0£200M£400M£600M£800MFY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26£658.1M£285.3M
FY25£672.8M£19.3M
FY24£668.8M£7.9M
FY23£689.7M£33.3M
FY22£593.4M£40.9M
MarginsShare of revenue
  • Operating margin
  • Net margin
0%20%40%60%FY22FY23FY24FY25FY26
Show the numbers
YearOperating marginNet margin
FY2613.3%43.4%
FY256.3%2.9%
FY241%1.2%
FY235.9%4.8%
FY228.3%6.9%
Free cash flowOperating cash flow minus capital expenditure
−£150M−£100M−£50M£0£50M£100MFY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26£61.9M
FY25£53.8M
FY24£15M
FY23−£56.8M
FY22−£109.3M
Returned to shareholdersDividends paid and shares bought back
£0£10M£20M£30MFY22FY23FY24FY25FY26
Show the numbers
YearDividends
FY26£21.7M
FY25£21.1M
FY24£21M
FY23£21M
FY22£20.9M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Genus
  • Healthcare median
−100%−50%0%50%FY22FY23FY24FY25FY26
Show the numbers
YearGenusHealthcare median
FY2643.4%−11.1%
FY252.9%−30.6%
FY241.2%−47%
FY234.8%−58%
FY226.9%−80.4%